Osteopontin deficiency delays inflammatory infiltration and the onset of muscle regeneration in a mouse model of muscle injury

DMM Disease Models and Mechanisms

Volumn 6, Issue 1, 2013, Pages 197-205

  Uaesoontrachoon, Kitipong ^a,b   Wasgewatte Wijesinghe, Dimuthu K ^a   Mackie, Eleanor J ^a   Pagel, Charles N ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOPONTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; MACROPHAGE; MALE; MOUSE; MUSCLE CELL; MUSCLE INJURY; MUSCLE REGENERATION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION;

ANIMALS; DISEASE MODELS, ANIMAL; FIBROSIS; INFLAMMATION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MYOBLASTS, SKELETAL; NEUTROPHIL INFILTRATION; OSTEOPONTIN; REGENERATION; TRANSPLANTATION, AUTOLOGOUS; UP-REGULATION;

MUS;

EID: 84872063624     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.009993     Document Type: Article

References (50)

1. Austyn, J. M. and Gordon, S. (1981). F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol. 11, 805-815.
2. Banerjee, A., Apte, U. M., Smith, R. and Ramaiah, S. K. (2006). Higher neutrophil infiltration mediated by osteopontin is a likely contributing factor to the increased susceptibility of females to alcoholic liver disease. J. Pathol. 208, 473-485.
3. Barbosa-Souza, V., Contin, D. K., Filho, W. B., de Araújo, A. L., Irazusta, S. P. and da Cruz-Höfling, M. A. (2011). Osteopontin, a chemotactic protein with cytokine-like properties, is up-regulated in muscle injury caused by Bothrops lanceolatus (fer-delance) snake venom. Toxicon 58, 398-409.
4. Berman, J. S., Serlin, D., Li, X., Whitley, G., Hayes, J., Rishikof, D. C., Ricupero, D. A., Liaw, L., Goetschkes, M. and O'Regan, A. W. (2004). Altered bleomycin-induced lung fibrosis in osteopontin-deficient mice. Am. J. Physiol. Lung Cell Mol. Physiol. 286, L1311-L1318.
5. Boudiffa, M., Wade-Gueye, N. M., Guignandon, A., Vanden-Bossche, A., Sabido, O., Aubin, J. E., Jurdic, P., Vico, L., Lafage-Proust, M. H. and Malaval, L. (2010). Bone sialoprotein deficiency impairs osteoclastogenesis and mineral resorption in vitro. J. Bone Miner. Res. 25, 2669-2679.
6. Bridges, L. R. (1986). The association of cardiac muscle necrosis and inflammation with the degenerative and persistent myopathy of MDX mice. J. Neurol. Sci. 72, 147-157.
7. Briguet, A., Courdier-Fruh, I., Foster, M., Meier, T. and Magyar, J. P. (2004). Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse. Neuromuscul. Disord. 14, 675-682.
8. Denhardt, D. T. and Guo, X. (1993). Osteopontin: a protein with diverse functions. FASEB J. 7, 1475-1482.
9. Duvall, C. L., Taylor, W. R., Weiss, D., Wojtowicz, A. M. and Guldberg, R. E. (2007). Impaired angiogenesis, early callus formation, and late stage remodeling in fracture healing of osteopontin-deficient mice. J. Bone Miner. Res. 22, 286-297.
10. Duvall, C. L., Weiss, D., Robinson, S. T., Alameddine, F. M., Guldberg, R. E. and Taylor, W. R. (2008). The role of osteopontin in recovery from hind limb ischemia. Arterioscler. Thromb. Vasc. Biol. 28, 290-295.
11. Fleming, T. J., Fleming, M. L. and Malek, T. R. (1993). Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family. J. Immunol. 151, 2399-2408.
12. Giachelli, C. M., Lombardi, D., Johnson, R. J., Murry, C. E. and Almeida, M. (1998). Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am. J. Pathol. 152, 353-358.
13. Giacopelli, F., Marciano, R., Pistorio, A., Catarsi, P., Canini, S., Karsenty, G. and Ravazzolo, R. (2004). Polymorphisms in the osteopontin promoter affect its transcriptional activity. Physiol. Genomics 20, 87-96.
14. Grounds, M. D., Davies, M., Torrisi, J., Shavlakadze, T., White, J. and Hodgetts, S. (2005). Silencing TNFalpha activity by using Remicade or Enbrel blocks inflammation in whole muscle grafts: an in vivo bioassay to assess the efficacy of anti-cytokine drugs in mice. Cell Tissue Res. 320, 509-515.
15. Hansen-Smith, F. M. and Carlson, B. M. (1979). Cellular responses to free grafting of the extensor digitorum longus muscle of the rat. J. Neurol. Sci. 41, 149-173.
16. Harris, J. B., Vater, R., Wilson, M. and Cullen, M. J. (2003). Muscle fibre breakdown in venom-induced muscle degeneration. J. Anat. 202, 363-372.
17. Hashimoto, M., Sun, D., Rittling, S. R., Denhardt, D. T. and Young, W. (2007). Osteopontin-deficient mice exhibit less inflammation, greater tissue damage, and impaired locomotor recovery from spinal cord injury compared with wild-type controls. J. Neurosci. 27, 3603-3611.
18. Haslett, J. N., Sanoudou, D., Kho, A. T., Bennett, R. R., Greenberg, S. A., Kohane, I. S., Beggs, A. H. and Kunkel, L. M. (2002). Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle. Proc. Natl. Acad. Sci. USA 99, 15000-15005.
19. Hirata, A., Masuda, S., Tamura, T., Kai, K., Ojima, K., Fukase, A., Motoyoshi, K., Kamakura, K., Miyagoe-Suzuki, Y. and Takeda, S. (2003). Expression profiling of cytokines and related genes in regenerating skeletal muscle after cardiotoxin injection: a role for osteopontin. Am. J. Pathol. 163, 203-215.
20. Hirsch, S., Austyn, J. M. and Gordon, S. (1981). Expression of the macrophage-specific antigen F4/80 during differentiation of mouse bone marrow cells in culture. J. Exp. Med. 154, 713-725.
21. Hodgetts, S., Radley, H., Davies, M. and Grounds, M. D. (2006). Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFalpha function with Etanercept in mdx mice. Neuromuscul. Disord. 16, 591-602.
22. Huard, J., Li, Y. and Fu, F. H. (2002). Muscle injuries and repair: current trends in research. J. Bone Joint Surg. Am. 84, 822-832.
23. Lescaudron, L., Peltékian, E., Fontaine-Pérus, J., Paulin, D., Zampieri, M., Garcia, L. and Parrish, E. (1999). Blood borne macrophages are essential for the triggering of muscle regeneration following muscle transplant. Neuromuscul. Disord. 9, 72-80.
24. Liaw, L., Birk, D. E., Ballas, C. B., Whitsitt, J. S., Davidson, J. M. and Hogan, B. L. (1998). Altered wound healing in mice lacking a functional osteopontin gene (spp1). J. Clin. Invest. 101, 1468-1478.
25. McGeachie, J. K. and Grounds, M. D. (1987). Initiation and duration of muscle precursor replication after mild and severe injury to skeletal muscle of mice. An autoradiographic study. Cell Tissue Res. 248, 125-130.
26. Monfoulet, L., Malaval, L., Aubin, J. E., Rittling, S. R., Gadeau, A. P., Fricain, J. C. and Chassande, O. (2010). Bone sialoprotein, but not osteopontin, deficiency impairs the mineralization of regenerating bone during cortical defect healing. Bone 46, 447-452.
27. Morgan, J. E., Coulton, G. R. and Partridge, T. A. (1989). mdx muscle grafts retain the mdx phenotype in normal hosts. Muscle Nerve 12, 401-409.
28. Mori, R., Shaw, T. J. and Martin, P. (2008). Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring. J. Exp. Med. 205, 43-51.
29. Nguyen, H. X. and Tidball, J. G. (2003). Interactions between neutrophils and macrophages promote macrophage killing of rat muscle cells in vitro. J. Physiol. 547, 125-132.
30. O'Regan, A. and Berman, J. S. (2000). Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation. Int. J. Exp. Pathol. 81, 373-390.
31. O'Regan, A. W., Chupp, G. L., Lowry, J. A., Goetschkes, M., Mulligan, N. and Berman, J. S. (1999). Osteopontin is associated with T cells in sarcoid granulomas and has T cell adhesive and cytokine-like properties in vitro. J. Immunol. 162, 1024-1031.
32. Pardo, A., Gibson, K., Cisneros, J., Richards, T. J., Yang, Y., Becerril, C., Yousem, S., Herrera, I., Ruiz, V., Selman, M. et al. (2005). Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis. PLoS Med. 2, e251.
33. Pegoraro, E., Hoffman, E. P., Piva, L., Gavassini, B. F., Cagnin, S., Ermani, M., Bello, L., Soraru, G., Pacchioni, B., Bonifati, M. D. et al. (2011). SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy. Neurology 76, 219-226.
34. Petrof, B. J., Shrager, J. B., Stedman, H. H., Kelly, A. M. and Sweeney, H. L. (1993). Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl. Acad. Sci. USA 90, 3710-3714.
35. Pizza, F. X., Hernandez, I. J. and Tidball, J. G. (1998). Nitric oxide synthase inhibition reduces muscle inflammation and necrosis in modified muscle use. J. Leukoc. Biol. 64, 427-433.
36. Porter, J. D., Khanna, S., Kaminski, H. J., Rao, J. S., Merriam, A. P., Richmonds, C. R., Leahy, P., Li, J., Guo, W. and Andrade, F. H. (2002). A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum. Mol. Genet. 11, 263-272.
37. Rittling, S. R., Matsumoto, H. N., McKee, M. D., Nanci, A., An, X. R., Novick, K. E., Kowalski, A. J., Noda, M. and Denhardt, D. T. (1998). Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J. Bone Miner. Res. 13, 1101-1111.
38. Roberts, P. and McGeachie, J. K. (1990). Endothelial cell activation during angiogenesis in freely transplanted skeletal muscles in mice and its relationship to the onset of myogenesis. J. Anat. 169, 197-207.
39. Roberts, P. and McGeachie, J. K. (1992a). The effects of pre- and posttransplantation exercise on satellite cell activation and the regeneration of skeletal muscle transplants: a morphometric and autoradiographic study in mice. J. Anat. 180, 67-74.
40. Roberts, P. and McGeachie, J. K. (1992b). Propranolol retards revascularisation and impedes early myogenesis in regenerating skeletal muscle transplants: an autoradiographic and morphometric study in mice. J. Anat. 181, 101-111.
41. Roberts, P. and McGeachie, J. K. (1994). The enhancement of revascularisation of skeletal muscle transplants using the beta 2-agonist isoprenaline. J. Anat. 184, 309-318.
42. Sam, F., Xie, Z., Ooi, H., Kerstetter, D. L., Colucci, W. S., Singh, M. and Singh, K. (2004). Mice lacking osteopontin exhibit increased left ventricular dilation and reduced fibrosis after aldosterone infusion. Am. J. Hypertens. 17, 188-193.
43. Standal, T., Hjorth-Hansen, H., Rasmussen, T., Dahl, I. M., Lenhoff, S., Brenne, A. T., Seidel, C., Baykov, V., Waage, A., Børset, M. et al. (2004). Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma. Haematologica 89, 174-182.
44. Stedman, H. H., Sweeney, H. L., Shrager, J. B., Maguire, H. C., Panettieri, R. A., Petrof, B., Narusawa, M., Leferovich, J. M., Sladky, J. T. and Kelly, A. M. (1991). The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 352, 536-539.
45. Tidball, J. G. (2005). Inflammatory processes in muscle injury and repair. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288, R345-R353.
46. Tidball, J. G. and Wehling-Henricks, M. (2007). Macrophages promote muscle membrane repair and muscle fibre growth and regeneration during modified muscle loading in mice in vivo. J. Physiol. 578, 327-336.
47. Uaesoontrachoon, K., Yoo, H. J., Tudor, E. M., Pike, R. N., Mackie, E. J. and Pagel, C. N. (2008). Osteopontin and skeletal muscle myoblasts: association with muscle regeneration and regulation of myoblast function in vitro. Int. J. Biochem. Cell Biol. 40, 2303-2314.
48. Vetrone, S. A., Montecino-Rodriguez, E., Kudryashova, E., Kramerova, I., Hoffman, E. P., Liu, S. D., Miceli, M. C. and Spencer, M. J. (2009). Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta. J. Clin. Invest. 119, 1583-1594.
49. Vignaud, A., Hourde, C., Medja, F., Agbulut, O., Butler-Browne, G. and Ferry, A. (2010). Impaired skeletal muscle repair after ischemia-reperfusion injury in mice. J. Biomed. Biotechnol. 2010, 724914.
50. Zammit, P. S., Partridge, T. A. and Yablonka-Reuveni, Z. (2006). The skeletal muscle satellite cell: the stem cell that came in from the cold. J. Histochem. Cytochem. 54, 1177-1191.